| Year |
Citation |
Score |
| 2008 |
Cameron C, Woodliff J, McOlash L, Hari P, Bredeson C, Margolis D, Truitt RL. Use of a Potassium Channel Blocker to Inhibit Effector-Memory T Cells Isolated from Recipients of Allogeneic BMSCT. Blood. 112: 1154-1154. DOI: 10.1182/Blood.V112.11.1154.1154 |
0.483 |
|
| 2007 |
Keever-Taylor CA, Browning MB, Johnson BD, Truitt RL, Bredeson CN, Behn B, Tsao A. Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis. Cytotherapy. 9: 144-57. PMID 17453966 DOI: 10.1080/14653240601145223 |
0.496 |
|
| 2006 |
Xia G, Truitt RL, Johnson BD. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 12: 397-407. PMID 16545723 DOI: 10.1016/J.Bbmt.2005.11.519 |
0.511 |
|
| 2006 |
Rosenblum MD, Yancey KB, Olasz EB, Truitt RL. CD200, a "no danger" signal for hair follicles. Journal of Dermatological Science. 41: 165-74. PMID 16386879 DOI: 10.1016/J.Jdermsci.2005.11.003 |
0.601 |
|
| 2006 |
Keever-Taylor C, Browning M, Johnson B, Truitt R, Behn B. Rapamycin added to human CD25+ cell cultures activated through CD3/CD28 enriches for CD4+CD25+CD27+Foxp3+ regulatory T cells Biology of Blood and Marrow Transplantation. 12: 14. DOI: 10.1016/J.Bbmt.2005.11.046 |
0.455 |
|
| 2005 |
Rosenblum MD, Woodliff JE, Madsen NA, McOlash LJ, Keller MR, Truitt RL. Characterization of CD 200-receptor expression in the murine epidermis. The Journal of Investigative Dermatology. 125: 1130-8. PMID 16354182 DOI: 10.1111/J.0022-202X.2005.23948.X |
0.58 |
|
| 2005 |
Keever-Taylor C, Browning M, Johnson B, Behn B, Truitt R. Optimization of culture methods for the expansion of CD4+CD25+ regulatory T cells for potential clinical use Biology of Blood and Marrow Transplantation. 11: 44. DOI: 10.1016/J.Bbmt.2004.12.131 |
0.448 |
|
| 2004 |
Xia G, Kovochich M, Truitt RL, Johnson BD. Tracking ex vivo-expanded CD4+CD25+ and CD8+CD25+ regulatory T cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host disease. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 10: 748-60. PMID 15505606 DOI: 10.1016/J.Bbmt.2004.07.004 |
0.51 |
|
| 2004 |
Rosenblum MD, Olasz EB, Yancey KB, Woodliff JE, Lazarova Z, Gerber KA, Truitt RL. Expression of CD200 on epithelial cells of the murine hair follicle: a role in tissue-specific immune tolerance? The Journal of Investigative Dermatology. 123: 880-7. PMID 15482475 DOI: 10.1111/J.0022-202X.2004.23461.X |
0.623 |
|
| 2004 |
Truitt RL. The Mortimer M. Bortin Lecture: to destroy by the reaction of immunity: the search for separation of graft-versus-leukemia and graft-versus-host. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 10: 505-23. PMID 15282529 DOI: 10.1016/J.Bbmt.2004.05.005 |
0.356 |
|
| 2004 |
Browning MB, Woodliff JE, Konkol MC, Pati NT, Ghosh S, Truitt RL, Johnson BD. The T cell activation marker CD150 can be used to identify alloantigen-activated CD4(+)25+ regulatory T cells. Cellular Immunology. 227: 129-39. PMID 15135295 DOI: 10.1016/J.Cellimm.2004.03.003 |
0.519 |
|
| 2004 |
Rosenblum MD, Olasz E, Woodliff JE, Johnson BD, Konkol MC, Gerber KA, Orentas RJ, Sandford G, Truitt RL. CD200 is a novel p53-target gene involved in apoptosis-associated immune tolerance. Blood. 103: 2691-8. PMID 14644999 DOI: 10.1182/Blood-2003-09-3184 |
0.583 |
|
| 2004 |
Woodliff J, Taylor C, Douek D, Margolis D, Drobyski W, Johnson B, Truitt R. Early production of donor-derived CD4+ CD25+ regulatory T cells in patients given hematopoietic stem cell transplants Biology of Blood and Marrow Transplantation. 10: 25. DOI: 10.1016/J.Bbmt.2003.12.102 |
0.523 |
|
| 2003 |
Truitt RL. Targeting DCs to induce regulatory T cells in vivo Blood. 101: 4649-4650. DOI: 10.1182/Blood-2003-04-1073 |
0.361 |
|
| 2003 |
Xia G, Yan X, Cao O, Truitt R, Johnson B. 85 A critical role for CD4+CD25+ suppressor cells in controlling GVHD after DLI in murine bone marrow chimeras Biology of Blood and Marrow Transplantation. 9: 90. DOI: 10.1016/S1083-8791(03)80086-1 |
0.377 |
|
| 2003 |
Browning M, Woodliff J, Konkol M, Pati N, Truitt R, Johnson B. 52 CD150 as a potential marker for alloactivated CD4+25+ regulatory T cells Biology of Blood and Marrow Transplantation. 9: 80. DOI: 10.1016/S1083-8791(03)80053-8 |
0.476 |
|
| 2002 |
Johnson BD, Konkol MC, Truitt RL. CD25+ immunoregulatory T-cells of donor origin suppress alloreactivity after BMT. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 8: 525-35. PMID 12434947 DOI: 10.1053/Bbmt.2002.V8.Pm12434947 |
0.562 |
|
| 2002 |
LaBelle JL, Truitt RL. Characterization of a murine NKT cell tumor previously described as an acute myelogenous leukemia. Leukemia & Lymphoma. 43: 1637-44. PMID 12400607 DOI: 10.1080/1042819021000002974 |
0.469 |
|
| 2002 |
LaBelle JL, Hanke CA, Blazar BR, Truitt RL. Negative effect of CTLA-4 on induction of T-cell immunity in vivo to B7-1+, but not B7-2+, murine myelogenous leukemia. Blood. 99: 2146-53. PMID 11877291 DOI: 10.1182/Blood.V99.6.2146 |
0.424 |
|
| 2001 |
Johnson BD, Dagher N, Stankowski MC, Hanke CA, Truitt RL. Donor natural killer (NK1.1+) cells do not play a role in the suppression of GVHD or in the mediation of GVL reactions after DLI Biology of Blood and Marrow Transplantation. 7: 589-595. PMID 11760146 DOI: 10.1053/Bbmt.2001.V7.Pm11760146 |
0.489 |
|
| 2000 |
Kugathasan S, Stein DJ, Truitt RL, Binion DG. Distinct mucosal T cell phenotypes in early and late pediatric Crohn's disease (CD): Increased naive T cells are found in late, but not early CD Gastroenterology. 118: A347. DOI: 10.1016/S0016-5085(00)83488-5 |
0.39 |
|
| 1999 |
Johnson BD, Becker EE, LaBelle JL, Truitt RL. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy. Journal of Immunology (Baltimore, Md. : 1950). 163: 6479-87. PMID 10586039 |
0.497 |
|
| 1999 |
Truitt RL, Johnson BD, Hanke C, Talib S, Hearst JE. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation. Journal of Immunology (Baltimore, Md. : 1950). 163: 5145-56. PMID 10528221 |
0.424 |
|
| 1999 |
Johnson BD, Becker EE, Truitt RL. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 5: 123-32. PMID 10392958 DOI: 10.1053/Bbmt.1999.V5.Pm10392958 |
0.533 |
|
| 1998 |
Johnson BD, Hanke CA, Becker EE, Truitt RL. Sca1(+)/Mac1(+) nitric oxide-producing cells in the spleens of recipients early following bone marrow transplant suppress T cell responses in vitro. Cellular Immunology. 189: 149-59. PMID 9790729 DOI: 10.1006/Cimm.1998.1373 |
0.494 |
|
| 1998 |
Truitt RL, Hanke C, Radke J, Mueller R, Barbieri JT. Glycosphingolipids as Novel Targets for T-Cell Suppression by the B Subunit of Recombinant Heat-Labile Enterotoxin Infection and Immunity. 66: 1299-1308. PMID 9529046 DOI: 10.1128/Iai.66.4.1299-1308.1998 |
0.491 |
|
| 1996 |
Johnson BD, Hanke CA, Truitt RL. The graft-versus-leukemia effect of post-transplant donor leukocyte infusion Leukemia and Lymphoma. 23: 1-9. PMID 9021679 DOI: 10.3109/10428199609054795 |
0.385 |
|
| 1996 |
Keever-Taylor CA, Witt PL, Truitt RL, Ramanujam S, Borden EC, Ritch PS. Hematologic and immunologic evaluation of recombinant human interleukin-6 in patients with advanced malignant disease: evidence for monocyte activation. Journal of Immunotherapy With Emphasis On Tumor Immunology : Official Journal of the Society For Biological Therapy. 19: 231-43. PMID 8811498 DOI: 10.1097/00002371-199605000-00008 |
0.439 |
|
| 1996 |
Margolis D, Camitta B, Pietryga D, Keever-Taylor C, Baxter-Lowe LA, Pierce K, Kupst MJ, French J, Truitt R, Lawton C, Murray K, Garbrecht F, Flomenberg N, Casper J. Unrelated donor bone marrow transplantation to treat severe aplastic anaemia in children and young adults. British Journal of Haematology. 94: 65-72. PMID 8757510 DOI: 10.1046/J.1365-2141.1996.D01-1772.X |
0.432 |
|
| 1996 |
Flomenberg P, Piaskowski V, Truitt RL, Casper JT. Human adenovirus-specific CD8+ T-cell responses are not inhibited by E3-19K in the presence of gamma interferon Journal of Virology. 70: 6314-6322. PMID 8709259 DOI: 10.1128/Jvi.70.9.6314-6322.1996 |
0.402 |
|
| 1996 |
D'Cunha J, Knight E, Haas AL, Truitt RL, Borden EC. Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proceedings of the National Academy of Sciences of the United States of America. 93: 211-5. PMID 8552607 DOI: 10.1073/Pnas.93.1.211 |
0.431 |
|
| 1995 |
Johnson BD, Truitt RL. Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance and allows for persistent antileukemic reactivity without severe graft-versus-host disease Blood. 85: 3302-3312. PMID 7756664 DOI: 10.1182/Blood.V85.11.3302.Bloodjournal85113302 |
0.521 |
|
| 1995 |
Flomenberg P, Piaskowski V, Truitt RL, Casper JT. Characterization of human proliferative t cell responses to adenovirus Journal of Infectious Diseases. 171: 1090-1096. PMID 7751682 DOI: 10.1093/Infdis/171.5.1090 |
0.455 |
|
| 1995 |
Johnson BD, McCabe C, Hanke CA, Truitt RL. Use of anti-CD3ε F(ab')2 fragments in vivo to modulate graft-versus-host disease without loss of graft-versus-leukemia reactivity after MHC-matched bone marrow transplantation Journal of Immunology. 154: 5542-5554. PMID 7730653 |
0.403 |
|
| 1995 |
Ritch PS, Keever C, Schiller J, Rivkin S, Witt PL, Grossberg SE, Truitt RL, Burris H, von Hoff DD, Vaickus L. Phase IA/IB evaluation of mammalian cell-derived glycosylated recombinant human interleukin (SIGOSIX) before and after cytotoxic chemotherapy. Annals of the New York Academy of Sciences. 762: 359-60. PMID 7668536 DOI: 10.1111/J.1749-6632.1995.Tb32340.X |
0.301 |
|
| 1995 |
Casper J, Camitta B, Truitt R, Baxter-Lowe L, Bunin N, Lawton C, Murray K, Hunter J, Pietryga D, Garbrecht F. Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia Blood. 85: 2354-2363. DOI: 10.1182/Blood.V85.9.2354.Bloodjournal8592354 |
0.376 |
|
| 1993 |
Johnson BD, Drobyski WR, Truitt RL. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease Bone Marrow Transplantation. 11: 329-336. PMID 8485480 |
0.428 |
|
| 1993 |
Drobyski W, Baxter-Lowe L, Truitt R. Detection of residual leukemia by the polymerase chain reaction and sequence-specific oligonucleotide probe hybridization after allogeneic bone marrow transplantation for AKR leukemia: a murine model for minimal residual disease Blood. 81: 551-559. DOI: 10.1182/Blood.V81.2.551.Bloodjournal812551 |
0.383 |
|
| 1993 |
Truitt RL, Johnson BD, Eisenberg N, McCabe C. USE OF T-CELL SPECIFIC MONOCLONAL ANTIBODIES TO MANIPULATE GRAFT-VS-HOST (GVH) and GRAFT-VS-LEUKEMIA (GVL) REACTIONS AFTER BMT IN MICE Journal of Immunotherapy. 14: 369. DOI: 10.1097/00002371-199311000-00065 |
0.411 |
|
| 1992 |
Johnson BD, Truitt RL. A decrease in graft-vs.-host disease without loss of graft-vs.-leukemia reactivity after MHC-matched bone marrow transplantation by selective depletion of donor nk cells in vivo Transplantation. 54: 104-112. PMID 1631918 DOI: 10.1097/00007890-199207000-00019 |
0.545 |
|
| 1992 |
Truitt RL, Piaskowski V, Kirchner P, McOlash L, Camitta BM, Casper JT. Immunological evaluation of pediatric cancer patients receiving recombinant interleukin-2 in a phase I trial Journal of Immunotherapy. 11: 274-285. PMID 1599913 DOI: 10.1097/00002371-199205000-00006 |
0.458 |
|
| 1991 |
Truitt RL, Atasoylu AA. Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation Blood. 77: 2515-2523. PMID 2039833 DOI: 10.1182/Blood.V77.11.2515.Bloodjournal77112515 |
0.497 |
|
| 1991 |
Truitt RL, Atasoylu AA. Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow Bone Marrow Transplantation. 8: 51-58. PMID 1833016 |
0.506 |
|
| 1991 |
Lefever AV, Piaskowski VD, Casper JT, Truitt RL. Kinetic analysis of human IL-2 activated cytotoxic cells Immunopharmacology and Immunotoxicology. 13: 147-168. PMID 1770217 DOI: 10.3109/08923979109019697 |
0.4 |
|
| 1990 |
Ash RC, Casper JT, Chitambar CR, Hansen R, Bunin N, Truitt RL, Lawton C, Murray K, Hunter J, Baxter-Lowe LA, Gottschall JL, Oldham K, Anderson T, Camitta B, Menitove J. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors New England Journal of Medicine. 322: 485-494. PMID 2300120 DOI: 10.1056/Nejm199002223220801 |
0.421 |
|
| 1990 |
Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringdén O, Rozman C, Speck B, Truitt RL, Zwaan FE, Bortin MM. Graft-versus-leukemia reactions after bone marrow transplantation Blood. 75: 555-562. PMID 2297567 |
0.35 |
|
| 1990 |
Drobyski WR, Piaskowski V, Ash RC, Casper JT, Truitt RL. Preservation of lymphokine-activated killer activity following T cell depletion of human bone marrow. Transplantation. 50: 625-32. PMID 1699309 DOI: 10.1097/00007890-199010000-00020 |
0.557 |
|
| 1989 |
Bunin NJ, Casper JT, Chitambar C, Hunter J, Truitt R, Menitove J, Camitta BM, Ash R. Partially matched bone marrow transplantation in patients with myelodysplastic syndromes. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 6: 1851-5. PMID 3058877 DOI: 10.1200/Jco.1988.6.12.1851 |
0.392 |
|
| 1989 |
Drobyski W, Thibodeau S, Truitt RL, Baxter-Lowe LA, Gorski J, Jenkins R, Gottschall J, Ash RC. Third-party-mediated graft rejection and graft-versus-host disease after T-cell-depleted bone marrow transplantation, as demonstrated by hypervariable DNA probes and HLA-DR polymorphism. Blood. 74: 2285-94. PMID 2572285 |
0.361 |
|
| 1989 |
Liepins A, Lefever A, Truitt RL. Serotonin modulated CA+plus; dependent k+ channels in alloimmune effector cell lytic function Immunopharmacology and Immunotoxicology. 11: 165-178. PMID 2559929 DOI: 10.3109/08923978909005363 |
0.301 |
|
| 1989 |
Marmont AM, Gale RP, Butturini A, Goldman JM, Martelli MF, Prentice HG, Slavin S, Storb R, Truitt RL, Van Bekkum DW. T-cell depletion in allogeneic bone marrow transplantation: progress and problems Haematologica. 74: 235-248. PMID 2511092 |
0.301 |
|
| 1989 |
Drobyski W, Thibodeau S, Truitt R, Baxter-Lowe L, Gorski J, Jenkins R, Gottschall J, Ash R. Third-party-mediated graft rejection and graft-versus-host disease after T-cell-depleted bone marrow transplantation, as demonstrated by hypervariable DNA probes and HLA-DR polymorphism Blood. 74: 2285-2294. DOI: 10.1182/Blood.V74.6.2285.Bloodjournal7462285 |
0.455 |
|
| 1987 |
Shih CC, Truitt RL. A class II antigen-specific T cell clone can suppress graft-versus-host reactivity in murine allogeneic bone marrow chimeras Transplantation Proceedings. 19: 2664-2667. PMID 2950639 |
0.317 |
|
| 1987 |
LeFever AV, Truitt RL. Kinetic analysis of Qa-1-specific cloned cytotoxic T lymphocytes: Lytic parameters and evaluation of cellular inhibition Scandinavian Journal of Immunology. 25: 541-553. PMID 2440099 DOI: 10.1111/J.1365-3083.1987.Tb01080.X |
0.34 |
|
| 1986 |
Truitt RL, Shih CCY, Lefever AV. Manipulation of graft–versus–host disease for a graft–versus–leukemia effect after allogeneic bone marrow transplantation in akr mice with spontaneous leukemia/lymphoma Transplantation. 41: 301-310. PMID 3513389 DOI: 10.1097/00007890-198603000-00005 |
0.453 |
|
| 1986 |
LeFever AV, Truitt RL. Kinetic analysis of cloned cytotoxic T lymphocyte reactivity against normal and leukaemic target cells Journal of Immunogenetics. 13: 275-285. PMID 3493298 DOI: 10.1111/J.1744-313X.1986.Tb01112.X |
0.363 |
|
| 1985 |
LeFever AV, Truitt RL, Shih CCY. Reactivity of in-vitro-expanded alloimmune cytotoxic T lymphocytes and qa-1-specific cytotoxic T lymphocytes against AKR leukemia in vivo Transplantation. 40: 531-537. PMID 2414869 DOI: 10.1097/00007890-198511000-00012 |
0.484 |
|
| 1984 |
LeFever AV, Truitt RL, Shih CCY, Liepins A, Bortin MM. Migration patterns and functional activity of cloned cytotoxic T lymphocytes in syngeneic and allogeneic mice Transplantation. 37: 410-417. PMID 6200972 DOI: 10.1097/00007890-198404000-00020 |
0.368 |
|
| 1983 |
Shih CY, Truitt RL, Andreani M, Bortin MM. Growth of AKR T cell leukemia lymphoblasts in medium containing interleukin 2 (IL-2). In Vitro. 19: 759-66. PMID 6605296 DOI: 10.1007/Bf02618095 |
0.374 |
|
| 1983 |
Truitt RL, Shih CY, Lefever AV, Tempelis LD, Andreani M, Bortin MM. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo. Journal of Immunology (Baltimore, Md. : 1950). 131: 2050-8. PMID 6194224 |
0.373 |
|
| 1980 |
Bortin MM, Truitt RL, Shih CY, Rimm AA. Graft-versus-leukemia: allosensitization of MHC compatible donors induces antileukemic reactivity without amplification of antihost reactivity. Haematology and Blood Transfusion. 25: 31-9. PMID 7021349 DOI: 10.1007/978-3-642-67319-1_4 |
0.41 |
|
| 1980 |
Truitt RL, Bortin MM, Rimm AA. Alloimmunization: Induction of antileukemic reactivity without modification of anti-host reactivity in H-2-compatible mice Transplantation Proceedings. 12: 143-146. PMID 6966095 |
0.326 |
|
| 1979 |
Bortin MM, Truitt RL, Rimm AA, Bach FH. Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity [17] Nature. 281: 490-491. PMID 386133 DOI: 10.1038/281490A0 |
0.443 |
|
| 1977 |
Saltzstein EC, Rose WC, Truitt RL, Rimm AA, Bortin MM, Patillo RA. Growth of human tumors in lethally irradiated mice reconstituted with syngeneic fetal liver cells. Cancer. 39: 581-6. PMID 319894 DOI: 10.1002/1097-0142(197702)39:2<581::Aid-Cncr2820390231>3.0.Co;2-Y |
0.368 |
|
| 1976 |
Truitt RL, Pollard M. Allogeneic bone marrow chimerism in germ-free mice: IV. Therapy of “hodgkin’s-like” reticulum cell sarcoma in SJL mice Transplantation. 21: 12-16. PMID 1108322 DOI: 10.1097/00007890-197601000-00003 |
0.397 |
|
| 1976 |
Bortin MM, Truitt RL, Rose WC, Rimm AA, Saltzstein EC. Adoptive immunotherapy of spontaneous leukemia-lymphoma in AKR mice Advances in Experimental Medicine and Biology. 73: 331-339. PMID 793340 DOI: 10.1007/978-1-4684-3300-5_27 |
0.441 |
|
| 1976 |
Bortin MM, Rimm AA, Rose WC, Truitt RL, Saltzstein EC. Transplantation of hematopoietic and lymphoid cells in mice. Transplantation. 21: 331-6. PMID 7865 DOI: 10.1097/00007890-197604000-00010 |
0.412 |
|
| 1975 |
Bortin MM, Rose WC, Truitt RL, Rimm AA, Saltzstein EC, Rodey GE. Graft versus leukemia. VI. Adoptive immunotherapy in combination with chemoradiotherapy for spontaneous leukemia lymphoma in AKR mice Journal of the National Cancer Institute. 55: 1227-1230. PMID 1546 DOI: 10.1093/Jnci/55.5.1227 |
0.406 |
|
| 1974 |
Truitt RL, Pollard M, Srivastava KK. Allogeneic Bone Marrow Chimerism in Germfree Mice III. Therapy of Leukemic AKR Mice Proceedings of the Society For Experimental Biology and Medicine. 146: 153-158. PMID 4597165 DOI: 10.3181/00379727-146-38061 |
0.35 |
|
| 1974 |
Pollard M, Truitt RL. Allogeneic Bone Marrow Chimerism in Germ-free Mice. II. Prevention of Reticulum Cell Sarcomas in SJL/J Mice Proceedings of the Society For Experimental Biology and Medicine. 145: 488-492. PMID 4592169 DOI: 10.3181/00379727-145-37837 |
0.349 |
|
| 1973 |
Truitt RL, Shechmeister IL. The replication of bovine viral diarrhea mucosal disease virus in bovine leukocytes in vitro Arch.Ges.Virusforsch.. 42: 78-87. PMID 4749260 DOI: 10.1007/Bf01250509 |
0.303 |
|
| 1973 |
Pollard M, Truitt RL. Allogeneic Bone Marrow Chimerism in Germfree Mice. 1. Prevention of Spontaneous Leukemia in AKR Mice Proceedings of the Society For Experimental Biology and Medicine. 144: 659-665. PMID 4583624 DOI: 10.3181/00379727-144-37657 |
0.351 |
|
| Show low-probability matches. |